Stay updated on Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown in the page footer, replacing v3.3.3, a minor technical update with no effect on study details or navigation; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:59:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Locations section added with Ohio as a listed location. Ohio Locations and the HHS Vulnerability Disclosure footer were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:58.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; this is a minor UI/version change and does not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:55:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the government funding lapse banner from the page, an administrative notice not affecting study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:22:03.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A newer last update date and verification timestamps appear in Study Record Dates, while core study details (status, enrollment, eligibility, and procedures) remain unchanged.
    Difference
    0.3%
    Check dated 2025-10-27T20:55:26.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page now includes a government-operating status notice and a new resource topic, bumps the revision to v3.2.0, and removes the old v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T08:11:45.000Z thumbnail image

Stay in the know with updates to Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.